Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study |
| |
Authors: | Engel Jörg B Audebert Alain Frydman René Zivny Jaroslav Diedrich Klaus |
| |
Affiliation: | 1. Frauenklinik der Julius Maximilians-Universität Würzburg, Josef-Schneider-Str. 4, 97070 Würzburg, Germany;2. 35 rue de Turenne, 33000 Bordeaux, France;3. Hôpital Antoine-Béclère, Sce Gynéco-Obstétrique, 157 rue de la Porte de Trivaux, 92141 Clamart, France;4. Department of Obstetrics and Gynaecology, 1st Faculty of Medicine, Charles University, Apolinárská 18128, 51 Praha 2, Czech Republic;5. Klinik für Frauenheilkunde und Geburtshilfe, Universität Schleswig-Holstein, Campus Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany |
| |
Abstract: | ObjectiveTo assess the efficacy and safety of different dosing schedules of cetrorelix acetate as a short term treatment for 4 weeks prior to surgery in patients with uterine fibroids.Study designRandomized, double-blind, placebo-controlled study. Patients were 109 premenopausal women, with at least one uterine fibroid, more than 4 cm in diameter. Groups 1–3 received placebo, 5 and 10 mg of cetrorelix on days 1, 8, 15 and 22, respectively group 4 received 10 mg of cetrorelix on days 1 and 15. MRI scan was performed at screening and on day 29. The main outcome measure was the reduction of uterine volume on day 29 and response, defined as >30% size reduction.ResultsMean (±S.D.) reduction of uterine volume on day 29 (MRI scan) was 5.1 ± 32.1% with placebo, 15.6 ± 20.2% with 4 × 5 mg, 15.4 ± 34.6% with 4 × 10 mg and 0.6 ± 30.6% with 2 × 10 mg cetrorelix. Significant response versus placebo (p < 0.05) occurred in the 4 × 10 mg group (42.3% versus 11.1%)ConclusionsBest objective response after 4 weeks of treatment was achieved after therapy with 4 × 10 mg of cetrorelix acetate. Short term presurgical treatment with the LHRH-antagonist cetrorelix is a flexible treatment protocol without any major side effects. |
| |
Keywords: | Uterine myoma Cetrorelix GnRH antagonist Presurgical short term treatment |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|